RONAXAN 250 MG TABLETS FOR DOGS
RONAXAN 250 MG TABLETS FOR DOGS
Authorised
- Doxycycline hyclate
Product identification
Medicine name:
RONAXAN 250 MG COMPRIMES POUR CHIENS
RONAXAN 250 MG TABLETS FOR DOGS
Active substance:
- Doxycycline hyclate
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Doxycycline hyclate288.50/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Dog
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01AA02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Available in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/2416879 9/1989
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 13/11/2025
Combined File of all Documents
English (PDF)
Download Published on: 19/03/2025
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 13/11/2025
How useful was this page?:
